Company: ARTL
Filing Date: 2025-05-01
Form Type: 8-K
Source: 0001640334-25-000732
Chunk: 1

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-05-01
Form: 8-K
Item: Item 1.01
Chunk 1
---
 be immediately exercisable after issuance for five (5) years with an exercise price of such Warrant for each Warrant Share equal to the Minimum Price. Each Warrant will be exercisable by payment of the exercise price in cash or on a cashless basis if at the time of exercise there is no effective resale registration statement and will contain customary anti-dilution provisions (in the case of stock splits, dividends, recapitalizations, mergers and similar transactions).

Pursuant to the Subscription Agreements, the Company agreed (i) to file a registration statement (the “ Registration Statement”) with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”) on or before the 45th calendar day following the Maturity Date (subject to certain exceptions) for purposes of registering the resale of the Converted Shares, if any, and the shares issuable pursuant to the Warrants (collectively, the “Registrable Shares”), (ii) to use its reasonable best efforts to have such registration statement declared effective within the time period set forth in the Subscription Agreements, and (iii) to keep the Registration Statement effective until the Registrable Shares covered by such Registration Statement may be sold without volume or manner-of-sale restrictions pursuant to Rule 144, subject to certain conditions.

The Subscription Agreements contain customary representations, warranties and agreements by the Company, indemnification obligations of the Company and the Investors, including for liabilities under the Securities Act, and other obligations of the parties. The representations, warranties and covenants contained in the Subscription Agreements were made only for purposes of such Subscription Agreements and are made as of specific dates; are solely for the benefit of the parties (except as specifically set forth therein); may be subject to qualifications and limitations agreed upon by the parties in connection with negotiating the terms of the Subscription Agreements, instead of establishing matters as facts; and may be subject to standards of materiality and knowledge applicable to the contracting parties that differ from those applicable to the investors generally. Investors should not rely on the representations, warranties and covenants or any description thereof as characterizations of the actual state of facts or condition of the Company.

Certain directors, members of management and consultants of the Company entered into Subscription Agreements in connection with the Notes Offering and purchased an aggregate of $200,000 of Notes in the Notes Offering. The participation of these Investors in the Notes Offering was disclosed to, and approved by, the board and separately by the disinterested members of the